BIJUVA (estradiol-progesterone)
SELF ADMINISTRATION - Oral
Indications for Prior Authorization:
- Treatment of moderate to severe vasomotor symptoms due to menopause
Patients must meet the following criteria for the indication(s) above:
- Patient has a diagnosis of vasomotor symptoms associated with menopause, AND
- Patient has completed a trial of and had an inadequate response to or intolerance to oral estradiol 1 mg tablets and progesterone 100 mg capsules used concomitantly as separate products as documented in chart notes
Dosing:
- One 1 mg/100 mg capsule orally each evening with food
Approval:
- 1 year
Last review date: October 15, 2019